STOCK TITAN

[SCHEDULE 13G/A] Sotera Health Company SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

GTCR-affiliated investors report joint beneficial ownership of 103,038,253 shares of Sotera Health Co., representing 36.3% of outstanding common stock. The group holds 41,215,301 shares of record while Warburg Pincus affiliates are reported to hold 61,822,952 shares; together the holders are party to a Stockholders Agreement that coordinates voting on certain director elections. The ownership percentage is calculated using 284,046,606 shares outstanding as disclosed in Sotera Health's prospectus supplement. Each GTCR Reporting Person disclaims beneficial ownership of shares held of record by the Warburg Pincus parties, and the GTCR Reporting Persons state they do not have dispositive power over the Warburg Pincus–held shares except as set forth in the Stockholders Agreement.

Investitori affiliati a GTCR dichiarano la comproprietà congiunta di 103.038.253 azioni di Sotera Health Co., corrispondenti al 36,3% del capitale azionario ordinario in circolazione. Il gruppo detiene 41.215.301 azioni registrate mentre le affiliate di Warburg Pincus risultano titolari di 61.822.952 azioni; insieme le parti sono vincolate da un Accordo tra Azionisti che coordina il voto su alcune elezioni dei membri del consiglio. La percentuale di partecipazione è calcolata su 284.046.606 azioni in circolazione, come indicato nel supplemento al prospetto di Sotera Health. Ciascuna delle persone di riferimento GTCR nega la titolarità effettiva delle azioni registrate a nome delle parti di Warburg Pincus e dichiara di non avere il potere dispositive su tali azioni, salvo quanto previsto dall'Accordo tra Azionisti.

Inversores vinculados a GTCR informan la propiedad conjunta de 103.038.253 acciones de Sotera Health Co., que representan el 36,3% del capital social ordinario en circulación. El grupo posee 41.215.301 acciones registradas, mientras que las filiales de Warburg Pincus reportan 61.822.952 acciones; ambos accionistas están sujetos a un Acuerdo de Accionistas que coordina el voto en determinadas elecciones del consejo. El porcentaje de propiedad se calcula sobre 284.046.606 acciones en circulación, según el suplemento del folleto de Sotera Health. Cada Persona Informante de GTCR renuncia a la propiedad beneficiaria de las acciones registradas a nombre de las partes de Warburg Pincus y declara no tener poder dispositvo sobre esas acciones, salvo lo establecido en el Acuerdo de Accionistas.

GTCR 계열 투자자들은 Sotera Health Co.의 주식 103,038,253주를 공동 실소유하고 있다고 보고했으며, 이는 발행 보통주 중 36.3%에 해당합니다. 그룹은 장부상 41,215,301주를 보유하고 있고 Warburg Pincus 계열은 61,822,952주를 보유하는 것으로 보고됩니다. 양측은 일부 이사 선임에 대한 투표를 조정하는 주주간 계약에 참여하고 있습니다. 소유 비율은 Sotera Health의 증권 설명서 보충자료에 기재된 발행주식 284,046,606주를 기준으로 산정되었습니다. 각 GTCR 보고인은 Warburg Pincus 측이 장부상 보유한 주식의 실질적 소유를 부인하며, 주주간 계약에 명시된 경우를 제외하고는 해당 주식에 대한 처분권을 갖고 있지 않다고 밝혔습니다.

Des investisseurs affiliés à GTCR déclarent la propriété bénéficiaire conjointe de 103 038 253 actions de Sotera Health Co., soit 36,3 % du capital social ordinaire en circulation. Le groupe détient 41 215 301 actions inscrites au registre tandis que des affiliés de Warburg Pincus détiennent 61 822 952 actions ; ensemble, ils sont parties à un accord d'actionnaires qui coordonne les votes pour certaines élections de l'administrateur. Le pourcentage de détention est calculé sur la base de 284 046 606 actions en circulation, comme indiqué dans le supplément au prospectus de Sotera Health. Chaque personne déclarant pour GTCR décline la propriété bénéficiaire des actions inscrites au nom des parties Warburg Pincus et précise ne pas exercer de pouvoir de disposition sur ces actions, sauf dans les cas prévus par l'accord d'actionnaires.

GTCR-nahe Investoren geben an, gemeinsam wirtschaftliches Eigentum an 103.038.253 Aktien von Sotera Health Co. zu halten, was 36,3 % des ausstehenden Stammkapitals entspricht. Die Gruppe hält 41.215.301 Aktien in ihren Büchern, während Tochtergesellschaften von Warburg Pincus mit 61.822.952 Aktien ausgewiesen sind; gemeinsam sind die Inhaber Partei eines Aktionärsvertrags, der die Abstimmung bei bestimmten Vorstandsneuwahlen koordiniert. Der Eigentumsanteil basiert auf 284.046.606 ausstehenden Aktien, wie im Nachtragsprospekt von Sotera Health angegeben. Jede GTCR-Meldeperson bestreitet das wirtschaftliche Eigentum an den von den Warburg Pincus-Parteien gehaltenen eingetragenen Aktien und erklärt, außer wie im Aktionärsvertrag geregelt, keine Verfügungsgewalt über diese Aktien zu haben.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: A coordinated block controls over one-third of Sotera Health's shares, which is material for governance and strategic influence.

The filing shows the GTCR Reporting Persons and Warburg Pincus affiliates together hold 103,038,253 shares (36.3% of the class based on 284,046,606 shares outstanding). That stake is large enough to materially influence board composition and strategic decisions through the Stockholders Agreement; however, GTCR expressly disclaims beneficial ownership of the Warburg Pincus-recorded shares, limiting clear dispositive control attributable solely to GTCR to the 41,215,301 shares it holds of record. Investors should view this as an impactful ownership grouping disclosed for governance transparency rather than an immediate change in corporate operations.

TL;DR: The Stockholders Agreement creates coordinated voting power among major private-equity holders, raising governance significance.

The Schedule 13G/A identifies a formal Stockholders Agreement between GTCR funds, Warburg Pincus sponsors and certain other holders that coordinates votes on director elections and includes transfer restrictions and indemnities. Although joint filing suggests group status, the GTCR Reporting Persons repeatedly disclaim beneficial ownership of shares held by Warburg Pincus, which preserves reporting separation while acknowledging practical coordination. This arrangement is governance-impactful by concentrating voting alignment without consolidating record ownership.

Investitori affiliati a GTCR dichiarano la comproprietà congiunta di 103.038.253 azioni di Sotera Health Co., corrispondenti al 36,3% del capitale azionario ordinario in circolazione. Il gruppo detiene 41.215.301 azioni registrate mentre le affiliate di Warburg Pincus risultano titolari di 61.822.952 azioni; insieme le parti sono vincolate da un Accordo tra Azionisti che coordina il voto su alcune elezioni dei membri del consiglio. La percentuale di partecipazione è calcolata su 284.046.606 azioni in circolazione, come indicato nel supplemento al prospetto di Sotera Health. Ciascuna delle persone di riferimento GTCR nega la titolarità effettiva delle azioni registrate a nome delle parti di Warburg Pincus e dichiara di non avere il potere dispositive su tali azioni, salvo quanto previsto dall'Accordo tra Azionisti.

Inversores vinculados a GTCR informan la propiedad conjunta de 103.038.253 acciones de Sotera Health Co., que representan el 36,3% del capital social ordinario en circulación. El grupo posee 41.215.301 acciones registradas, mientras que las filiales de Warburg Pincus reportan 61.822.952 acciones; ambos accionistas están sujetos a un Acuerdo de Accionistas que coordina el voto en determinadas elecciones del consejo. El porcentaje de propiedad se calcula sobre 284.046.606 acciones en circulación, según el suplemento del folleto de Sotera Health. Cada Persona Informante de GTCR renuncia a la propiedad beneficiaria de las acciones registradas a nombre de las partes de Warburg Pincus y declara no tener poder dispositvo sobre esas acciones, salvo lo establecido en el Acuerdo de Accionistas.

GTCR 계열 투자자들은 Sotera Health Co.의 주식 103,038,253주를 공동 실소유하고 있다고 보고했으며, 이는 발행 보통주 중 36.3%에 해당합니다. 그룹은 장부상 41,215,301주를 보유하고 있고 Warburg Pincus 계열은 61,822,952주를 보유하는 것으로 보고됩니다. 양측은 일부 이사 선임에 대한 투표를 조정하는 주주간 계약에 참여하고 있습니다. 소유 비율은 Sotera Health의 증권 설명서 보충자료에 기재된 발행주식 284,046,606주를 기준으로 산정되었습니다. 각 GTCR 보고인은 Warburg Pincus 측이 장부상 보유한 주식의 실질적 소유를 부인하며, 주주간 계약에 명시된 경우를 제외하고는 해당 주식에 대한 처분권을 갖고 있지 않다고 밝혔습니다.

Des investisseurs affiliés à GTCR déclarent la propriété bénéficiaire conjointe de 103 038 253 actions de Sotera Health Co., soit 36,3 % du capital social ordinaire en circulation. Le groupe détient 41 215 301 actions inscrites au registre tandis que des affiliés de Warburg Pincus détiennent 61 822 952 actions ; ensemble, ils sont parties à un accord d'actionnaires qui coordonne les votes pour certaines élections de l'administrateur. Le pourcentage de détention est calculé sur la base de 284 046 606 actions en circulation, comme indiqué dans le supplément au prospectus de Sotera Health. Chaque personne déclarant pour GTCR décline la propriété bénéficiaire des actions inscrites au nom des parties Warburg Pincus et précise ne pas exercer de pouvoir de disposition sur ces actions, sauf dans les cas prévus par l'accord d'actionnaires.

GTCR-nahe Investoren geben an, gemeinsam wirtschaftliches Eigentum an 103.038.253 Aktien von Sotera Health Co. zu halten, was 36,3 % des ausstehenden Stammkapitals entspricht. Die Gruppe hält 41.215.301 Aktien in ihren Büchern, während Tochtergesellschaften von Warburg Pincus mit 61.822.952 Aktien ausgewiesen sind; gemeinsam sind die Inhaber Partei eines Aktionärsvertrags, der die Abstimmung bei bestimmten Vorstandsneuwahlen koordiniert. Der Eigentumsanteil basiert auf 284.046.606 ausstehenden Aktien, wie im Nachtragsprospekt von Sotera Health angegeben. Jede GTCR-Meldeperson bestreitet das wirtschaftliche Eigentum an den von den Warburg Pincus-Parteien gehaltenen eingetragenen Aktien und erklärt, außer wie im Aktionärsvertrag geregelt, keine Verfügungsgewalt über diese Aktien zu haben.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person: (1) As more fully described in Item 4 of this Amendment No. 3 to Schedule 13G, the GTCR Investors are party to a Stockholders Agreement with the Warburg Pincus Investors and certain other holders of Common Stock of the Issuer. The GTCR Investors, together with the Warburg Pincus Investors, hold an aggregate total of 103,038,253 shares of Common Stock of the Issuer (approximately 36.3% of the outstanding shares of Common Stock of the Issuer), of which 61,822,952 shares of Common Stock are publicly reported as being owned by the Warburg Pincus Investors in such entities' Form 4, filed with the U.S. Securities and Exchange Commission ("Commission") September 9, 2025. Although the GTCR Reporting Persons may be deemed to beneficially own the Common Stock held as of record by the Warburg Pincus Investors as a result of the Stockholders Agreement, each GTCR Reporting Person expressly disclaims beneficial ownership (within the meaning of Rule 13d-3 of the Securities Exchange Act of 1934, as amended (the "Exchange Act")) with respect to any shares of Common Stock other than the shares of Common Stock of the Issuer owned of record by such GTCR Reporting Person. The percentages used herein have been determined in accordance with footnote 2 below. Capitalized terms used herein are defined in Items 2(a) or 4 below. (2) Calculated based on 284,046,606 shares of Common Stock outstanding as of July 29, 2025 as reported on the Issuer's final prospectus supplement, filed pursuant to Rule 424(b)(7) on September 4, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person: (1) As more fully described in Item 4 of this Amendment No. 3 to Schedule 13G, the GTCR Investors are party to a Stockholders Agreement with the Warburg Pincus Investors and certain other holders of Common Stock of the Issuer. The GTCR Investors, together with the Warburg Pincus Investors, hold an aggregate total of 103,038,253 shares of Common Stock of the Issuer (approximately 36.3% of the outstanding shares of Common Stock of the Issuer), of which 61,822,952 shares of Common Stock are publicly reported as being owned by the Warburg Pincus Investors in such entities' Form 4, filed with the Commission September 9, 2025. Although the GTCR Reporting Persons may be deemed to beneficially own the Common Stock held as of record by the Warburg Pincus Investors as a result of the Stockholders Agreement, each GTCR Reporting Person expressly disclaims beneficial ownership (within the meaning of Rule 13d-3 of the Exchange Act) with respect to any shares of Common Stock other than the shares of Common Stock of the Issuer owned of record by such GTCR Reporting Person. The percentages used herein have been determined in accordance with footnote 2 below. Capitalized terms used herein are defined in Items 2(a) or 4 below. (2) Calculated based on 284,046,606 shares of Common Stock outstanding as of July 29, 2025 as reported on the Issuer's final prospectus supplement, filed pursuant to Rule 424(b)(7) on September 4, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person: (1) As more fully described in Item 4 of this Amendment No. 3 to Schedule 13G, the GTCR Investors are party to a Stockholders Agreement with the Warburg Pincus Investors and certain other holders of Common Stock of the Issuer. The GTCR Investors, together with the Warburg Pincus Investors, hold an aggregate total of 103,038,253 shares of Common Stock of the Issuer (approximately 36.3% of the outstanding shares of Common Stock of the Issuer), of which 61,822,952 shares of Common Stock are publicly reported as being owned by the Warburg Pincus Investors in such entities' Form 4, filed with the Commission September 9, 2025. Although the GTCR Reporting Persons may be deemed to beneficially own the Common Stock held as of record by the Warburg Pincus Investors as a result of the Stockholders Agreement, each GTCR Reporting Person expressly disclaims beneficial ownership (within the meaning of Rule 13d-3 of the Exchange Act) with respect to any shares of Common Stock other than the shares of Common Stock of the Issuer owned of record by such GTCR Reporting Person. The percentages used herein have been determined in accordance with footnote 2 below. Capitalized terms used herein are defined in Items 2(a) or 4 below. (2) Calculated based on 284,046,606 shares of Common Stock outstanding as of July 29, 2025 as reported on the Issuer's final prospectus supplement, filed pursuant to Rule 424(b)(7) on September 4, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person: (1) As more fully described in Item 4 of this Amendment No. 3 to Schedule 13G, the GTCR Investors are party to a Stockholders Agreement with the Warburg Pincus Investors and certain other holders of Common Stock of the Issuer. The GTCR Investors, together with the Warburg Pincus Investors, hold an aggregate total of 103,038,253 shares of Common Stock of the Issuer (approximately 36.3% of the outstanding shares of Common Stock of the Issuer), of which 61,822,952 shares of Common Stock are publicly reported as being owned by the Warburg Pincus Investors in such entities' Form 4, filed with the Commission September 9, 2025. Although the GTCR Reporting Persons may be deemed to beneficially own the Common Stock held as of record by the Warburg Pincus Investors as a result of the Stockholders Agreement, each GTCR Reporting Person expressly disclaims beneficial ownership (within the meaning of Rule 13d-3 of the Exchange Act) with respect to any shares of Common Stock other than the shares of Common Stock of the Issuer owned of record by such GTCR Reporting Person. The percentages used herein have been determined in accordance with footnote 2 below. Capitalized terms used herein are defined in Items 2(a) or 4 below. (2) Calculated based on 284,046,606 shares of Common Stock outstanding as of July 29, 2025 as reported on the Issuer's final prospectus supplement, filed pursuant to Rule 424(b)(7) on September 4, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person: (1) As more fully described in Item 4 of this Amendment No. 3 to Schedule 13G, the GTCR Investors are party to a Stockholders Agreement with the Warburg Pincus Investors and certain other holders of Common Stock of the Issuer. The GTCR Investors, together with the Warburg Pincus Investors, hold an aggregate total of 103,038,253 shares of Common Stock of the Issuer (approximately 36.3% of the outstanding shares of Common Stock of the Issuer), of which 61,822,952 shares of Common Stock are publicly reported as being owned by the Warburg Pincus Investors in such entities' Form 4, filed with the Commission September 9, 2025. Although the GTCR Reporting Persons may be deemed to beneficially own the Common Stock held as of record by the Warburg Pincus Investors as a result of the Stockholders Agreement, each GTCR Reporting Person expressly disclaims beneficial ownership (within the meaning of Rule 13d-3 of the Exchange Act) with respect to any shares of Common Stock other than the shares of Common Stock of the Issuer owned of record by such GTCR Reporting Person. The percentages used herein have been determined in accordance with footnote 2 below. Capitalized terms used herein are defined in Items 2(a) or 4 below. (2) Calculated based on 284,046,606 shares of Common Stock outstanding as of July 29, 2025 as reported on the Issuer's final prospectus supplement, filed pursuant to Rule 424(b)(7) on September 4, 2025.


SCHEDULE 13G



GTCR INVESTMENT XI LLC
Signature:/s/ Jeffrey Wright
Name/Title:Jeffrey Wright, Chief Legal Officer
Date:09/09/2025
GTCR FUND XI/A LP
Signature:/s/ Jeffrey Wright
Name/Title:Jeffrey Wright, Chief Legal Officer of GTCR Invest. XI LLC, the general partner of GTCR Partners XI/A&C LP, the general partner of GTCR FUND XI/A LP
Date:09/09/2025
GTCR FUND XI/C LP
Signature:/s/ Jeffrey Wright
Name/Title:Jeffrey Wright, Chief Legal Officer of GTCR Invest. XI LLC, the general partner of GTCR Partners XI/A&C LP, the general partner of GTCR FUND XI/C LP
Date:09/09/2025
GTCR CO-INVEST XI LP
Signature:/s/ Jeffrey Wright
Name/Title:Jeffrey Wright, Chief Legal Officer of GTCR Investment XI LLC, the general partner of GTCR CO-INVEST XI LP
Date:09/09/2025
GTCR PARTNERS XI/A&C LP
Signature:/s/ Jeffrey Wright
Name/Title:Jeffrey Wright, Chief Legal Officer of GTCR Investment XI LLC, the general partner of GTCR PARTNERS XI/A&C LP
Date:09/09/2025
Exhibit Information

Exhibit 99.1 Agreement of Joint Filing as required by Rule 13d-1(k)(1) under the Act.* * Incorporated herein by reference to the Agreement of Joint Filing by GTCR Investment XI LLC, GTCR Fund XI/A LP, GTCR Fund XI/C LP, GTCR Co-Invest XI LP and GTCR Partners XI/A&C LP dated as of February 11, 2022, which was previously filed with the Commission as Exhibit A to Amendment No. 1 to Schedule 13G filed by GTCR Investment XI LLC, GTCR Fund XI/A LP, GTCR Fund XI/C LP, GTCR Co-Invest XI LP and GTCR Partners XI/A&C LP on February 11, 2022 with respect to the shares of common stock of Sotera Health Co.

FAQ

How many Sotera Health (SHC) shares do the GTCR reporting persons jointly report?

They report an aggregate of 103,038,253 shares, representing 36.3% of the outstanding common stock based on 284,046,606 shares outstanding.

What portion of the reported stake is owned of record by the GTCR funds versus Warburg Pincus?

The GTCR XI Funds own 41,215,301 shares of record while Warburg Pincus affiliates are publicly reported to hold 61,822,952 shares.

Does the filing indicate coordinated voting among these holders?

Yes. The parties are party to a Stockholders Agreement that sets governance arrangements and coordinates voting on certain director elections.

Do the GTCR Reporting Persons claim full beneficial ownership of the combined block?

No. The GTCR Reporting Persons expressly disclaim beneficial ownership of shares held of record by the Warburg Pincus parties, except as specified in the Stockholders Agreement.

What share count was used to calculate the 36.3% figure for SHC?

The percentage is calculated using 284,046,606 shares outstanding as reported in Sotera Health's prospectus supplement.
Sotera Health Co

NASDAQ:SHC

SHC Rankings

SHC Latest News

SHC Latest SEC Filings

SHC Stock Data

4.54B
174.03M
2.46%
89.45%
3.99%
Diagnostics & Research
Services-misc Health & Allied Services, Nec
Link
United States
BROADVIEW HEIGHTS